Watchlist
Loading...
US Stock MarketDetailed Quotes

ALT Altimmune

Watchlist
6.480 -0.100-1.52% Close 12/08 16:00 ET
6.630+0.150+2.31% Pre 05:30 ET
7.410High6.370Low28.14MVolume
Pre-Market
  • 5D
  • 1D
  • 1W
  • 1M
  • 1Q
  • 1Y

About Altimmune Company

Altimmune, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH. In addition, Altimmune is developing HepTcell, an immunotherapeutic designed to achieve a functional cure for chronic hepatitis B. The company was founded in 1997 and is headquartered in Gaithersburg, MD.

Revenue Breakdown

Business Currency:USD
2022/12/31
Stock NameRevenueRatio
Single Segment-68K100.00%

Comments

Read more
Paper Trade Start
Symbol
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Claim up to $1 million virtual fund, join moomoo paper trading today! Claim Now >